4-Aminopyridine (INN fampridine, USAN dalfampridine) is an amoebic admixture with the actinic blueprint C5H4N–NH2. The atom is one of the three isomeric amines of pyridine. It is acclimated primarily as a analysis tool, in anecdotic subtypes of potassium channel, and has aswell been acclimated to administer some of the affection of assorted sclerosis, and is adumbrated for appropriate advance of walking in adults with several variations of the disease. The biologic has drop biologic cachet in the United States beneath the barter name Neurelan. It was ability Phase III analytic trials as of 2008, and the U.S. Food and Biologic Administration (FDA) accustomed the admixture on January 22, 2010. Fampridine is aswell marketed as Ampyra (pronounced "am-PEER-ah," according to the maker's website) in the United States by Acorda Therapeutics and as Fampyra in Europe.
4-Aminopyridine (4-AP) is able by the decarbonylation of pyridine-4-carboxamide appliance sodium hypochlorite via the Hofmann rearrangement. The pyridine carboxamide is generated from the agnate nitrile, which in about-face is acquired from ammoxidation of 4-methylpyridine.
Applications
The better calibration automated appliance of 4-aminopyridine is as a forerunner to the biologic pinacidil, which affects potassium ion channels.
In the laboratory, 4-AP is a advantageous pharmacological apparatus in belief assorted potassium conductances in analysis and biophysics. It is a almost careful acquaintance of associates of Kv1 (Shaker, KCNA) ancestors of voltage-activated K+ channels. At absorption of 1 mM it selectively and reversibly inhibits Shaker channels after cogent aftereffect on added sodium, calcium, and potassium conductances.
Vertebrate pesticide
4-Aminopyridine is aswell acclimated as a bird ascendancy agent, beneath the barter name Avitrol; it causes amusement and about death, depending on dosage. The use of 4-aminopyridine in bird ascendancy has been criticized by the Humane Society of the United States.
Fampridine has been acclimated clinically in Lambert-Eaton myasthenic affection and assorted sclerosis. It acts by blocking potassium channels, assiduity activity potentials and thereby accretion neurotransmitter absolution at the neuromuscular junction. The biologic has been apparent to about-face tetrodotoxin toxicity in beastly experiments.
More about: 4-Aminopyridine sale
Read more: Pyridine synthesis
lactobacillus bacteria, Lactic acid bacteria Manufacturers, Lactic acid bacteria Suppliers ,Acid lactic bacteria from http://www.lactic-acid-bacteria.net
Showing posts with label 4-Aminopyridine. Show all posts
Showing posts with label 4-Aminopyridine. Show all posts
Tuesday, April 17, 2012
Tuesday, March 20, 2012
Applications of 4-Aminopyridine
4-Aminopyridine (INN fampridine, USAN dalfampridine) is an organic compound with the chemical formula C5H4N–NH2. The molecule is one of the three isomeric amines of pyridine. It is used primarily as a research tool, in characterizing subtypes of potassium channel, and has also been used to manage some of the symptoms of multiple sclerosis, and is indicated for symptomatic improvement of walking in adults with several variations of the disease. The drug has orphan drug status in the United States under the trade name Neurelan. It was undergoing Phase III clinical trials as of 2008, and the U.S. Food and Drug Administration (FDA) approved the compound on January 22, 2010. Fampridine is also marketed as Ampyra (pronounced "am-PEER-ah," according to the maker's website) in the United States by Acorda Therapeutics and as Fampyra in Europe.
Applications
The largest scale industrial application of 4-Aminopyridine is as a precursor to the drug pinacidil, which affects potassium ion channels.
In the laboratory, 4-AP is a useful pharmacological tool in studying various potassium conductances in physiology and biophysics. It is a relatively selective blocker of members of Kv1 (Shaker, KCNA) family of voltage-activated K+ channels. At concentration of 1 mM it selectively and reversibly inhibits Shaker channels without significant effect on other sodium, calcium, and potassium conductances.
4-Aminopyridine is also used as a bird control agent, under the trade name Avitrol; it causes convulsions and typically death, depending on dosage. The use of 4-aminopyridine in bird control has been criticized by the Humane Society of the United States.
Medical use
Fampridine has been used clinically in Lambert-Eaton myasthenic syndrome and multiple sclerosis. It acts by blocking potassium channels, prolonging action potentials and thereby increasing neurotransmitter release at the neuromuscular junction. The drug has been shown to reverse tetrodotoxin toxicity in animal experiments.
More about: 4-Aminopyridine sale
Read more: Pyridine
Applications
The largest scale industrial application of 4-Aminopyridine is as a precursor to the drug pinacidil, which affects potassium ion channels.
In the laboratory, 4-AP is a useful pharmacological tool in studying various potassium conductances in physiology and biophysics. It is a relatively selective blocker of members of Kv1 (Shaker, KCNA) family of voltage-activated K+ channels. At concentration of 1 mM it selectively and reversibly inhibits Shaker channels without significant effect on other sodium, calcium, and potassium conductances.
4-Aminopyridine is also used as a bird control agent, under the trade name Avitrol; it causes convulsions and typically death, depending on dosage. The use of 4-aminopyridine in bird control has been criticized by the Humane Society of the United States.
Medical use
Fampridine has been used clinically in Lambert-Eaton myasthenic syndrome and multiple sclerosis. It acts by blocking potassium channels, prolonging action potentials and thereby increasing neurotransmitter release at the neuromuscular junction. The drug has been shown to reverse tetrodotoxin toxicity in animal experiments.
More about: 4-Aminopyridine sale
Read more: Pyridine
Subscribe to:
Posts (Atom)

